Our scientific team can develop assays to characterize your cell-based therapy in order to assess its suitability early in the development process, minimizing downstream risk. Characterization services include:
Our scientific team can develop release assays to ensure the safety, identity, purity, potency, and dose determination of your cell-based therapeutic product. Release testing services include:
Kincell Bio facilities are well equipped with a range of platform technologies, enabling us to provide comprehensive analytical solutions. Our analytical platform includes:
A dedicated Project Manager ensures your development program stays on track, at every step. Careful planning up-front is focused on defining a tailored control strategy and release testing paradigm, matching your program needs with available technologies to solve for key elements of the target product profile.
Throughout the analytical development process, we keep you informed with responsive communication.
Featured news
New contract reinforces Kincell Bio’s commitment to long-term partnerships to address development and GMP manufacturing support for engineered cellular therapies.
“One of the big things that I really enjoy about working at Kincell Bio is the opportunity to collaborate with our clients, supporting them in their process and analytical development journeys by leveraging advanced technologies tailored to their projects.”
“The dynamic relationship between departments, and collectively being vested in the success of each project is one of the best aspects of Kincell Bio.”
